Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin
32 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
32
Total Reports
29
Deaths Reported
9060.0%
Death Rate
Active Ingredients
Bovine Parainfluenza Virus 3 (Ts), Rlb103 (Nl-Bk-6), Mlv; Infectious Bovine Rhin
Administration Routes
UnknownNasal
Species Affected
Cattle 32
Most Affected Breeds
Cattle (other) 23
Mixed (Cattle) 6
Crossbred Bovine/Cattle 1
Maine-Anjou 1
Aberdeen Angus 1
Most Reported Reactions
Lack of efficacy (bacteria) - NOS 28
Death 20
Abnormal test result 10
CULTURE/TITER DATA ABNORMAL 9
Lack of efficacy - NOS 5
Increased mortality rate 4
Abnormal necropsy finding 4
NT - Abnormal necropsy finding NOS 3
Other abnormal test result NOS 3
Unrelated death 3
Joint swelling 2
PR-LUNG(S), LESION(S) 1
Outcome Breakdown
Died
29 (49.2%)
Outcome Unknown
23 (39.0%)
Ongoing
4 (6.8%)
Recovered/Normal
2 (3.4%)
Euthanized
1 (1.7%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.